US2006211090A1PendingUtilityA1
Human cDNAs and proteins and uses thereof
Est. expiryMay 25, 2021(expired)· nominal 20-yr term from priority
C07K 2319/02G01N 33/5023C07K 14/47A61P 35/00C12Q 1/6883A61P 35/02C07K 14/4711A01K 2217/05G01N 33/6896A61P 43/00A61K 48/00A61K 38/00A61P 35/04G01N 2800/2821
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
Claims
exact text as granted — not AI-modified1 . A composition of matter comprising:
a) an isolated polynucleotide encoding the polypeptide of SEQ ID NO: 6; b) an expression vector comprising a polynucleotide encoding the polypeptide of SEQ ID NO: 6; or c) a recombinant host cell comprising a polynucleotide encoding the polypeptide of SEQ ID NO: 6.
2 . The composition of matter according to claim 1 , wherein said polynucleotide comprises SEQ ID NO: 5.
3 . A method of making a polypeptide, said method comprising
a) providing a population of host cells comprising the polynucleotide of claim 1; b) culturing said population of host cells under conditions conducive to the production of a polypeptide comprising SEQ ID NO: 6; and c) purifying said polypeptide from said population of host cells.Join the waitlist — get patent alerts
Track US2006211090A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.